ArticleAnnals of translational medicine2022

Genome-wide screening and immune landscape suggest a potential-m6A-related lncRNA risk signature for predicting prognosis of melanoma.

Kangjie Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.